Edinburgh Cardiothoracic Surgeons Limited - Period Ending 2023-05-31

Edinburgh Cardiothoracic Surgeons Limited - Period Ending 2023-05-31


Edinburgh Cardiothoracic Surgeons Limited SC477619 false 2022-06-01 2023-05-31 2023-05-31 The principal activity of the company is Post graduate education and medical consultancy services. Digita Accounts Production Advanced 6.30.9574.0 true SC477619 2022-06-01 2023-05-31 SC477619 2023-05-31 SC477619 core:RetainedEarningsAccumulatedLosses 2023-05-31 SC477619 core:ShareCapital 2023-05-31 SC477619 core:CurrentFinancialInstruments 2023-05-31 SC477619 core:CurrentFinancialInstruments core:WithinOneYear 2023-05-31 SC477619 core:FurnitureFittingsToolsEquipment 2023-05-31 SC477619 bus:SmallEntities 2022-06-01 2023-05-31 SC477619 bus:AuditExemptWithAccountantsReport 2022-06-01 2023-05-31 SC477619 bus:FullAccounts 2022-06-01 2023-05-31 SC477619 bus:SmallCompaniesRegimeForAccounts 2022-06-01 2023-05-31 SC477619 bus:RegisteredOffice 2022-06-01 2023-05-31 SC477619 bus:Director1 2022-06-01 2023-05-31 SC477619 bus:PrivateLimitedCompanyLtd 2022-06-01 2023-05-31 SC477619 core:FurnitureFittingsToolsEquipment 2022-06-01 2023-05-31 SC477619 core:OfficeEquipment 2022-06-01 2023-05-31 SC477619 countries:Scotland 2022-06-01 2023-05-31 SC477619 2022-05-31 SC477619 core:FurnitureFittingsToolsEquipment 2022-05-31 SC477619 2021-06-01 2022-05-31 SC477619 2022-05-31 SC477619 core:RetainedEarningsAccumulatedLosses 2022-05-31 SC477619 core:ShareCapital 2022-05-31 SC477619 core:CurrentFinancialInstruments 2022-05-31 SC477619 core:CurrentFinancialInstruments core:WithinOneYear 2022-05-31 SC477619 core:FurnitureFittingsToolsEquipment 2022-05-31 iso4217:GBP xbrli:pure

Registration number: SC477619

Edinburgh Cardiothoracic Surgeons Limited

Unaudited Filleted Financial Statements

for the Year Ended 31 May 2023

 

Edinburgh Cardiothoracic Surgeons Limited

Contents

Balance Sheet

1

Notes to the Unaudited Financial Statements

2 to 4

 

Edinburgh Cardiothoracic Surgeons Limited

(Registration number: SC477619)
Balance Sheet as at 31 May 2023

Note

2023
£

2022
£

Fixed assets

 

Tangible assets

4

3,956

4,008

Current assets

 

Debtors

5

22

-

Cash at bank and in hand

 

210,882

103,984

 

210,904

103,984

Creditors: Amounts falling due within one year

6

(42,746)

(19,615)

Net current assets

 

168,158

84,369

Total assets less current liabilities

 

172,114

88,377

Provisions for liabilities

(910)

(762)

Net assets

 

171,204

87,615

Capital and reserves

 

Called up share capital

100

100

Retained earnings

171,104

87,515

Shareholders' funds

 

171,204

87,615

For the financial year ending 31 May 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 20 February 2024
 

.........................................
Mr Vipin Zamvar
Director

 

Edinburgh Cardiothoracic Surgeons Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 May 2023

1

General information

The company is a private company limited by share capital, incorporated in Scotland.

The address of its registered office is:
12 Redhall House Avenue
Edinburgh
Midlothian
EH14 1JJ

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

 

Edinburgh Cardiothoracic Surgeons Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 May 2023

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Office equipment

20% straight line

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 0 (2022 - 0).

 

Edinburgh Cardiothoracic Surgeons Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 May 2023

4

Tangible assets

Furniture, fittings and equipment
 £

Total
£

Cost or valuation

At 1 June 2022

15,551

15,551

Additions

2,259

2,259

At 31 May 2023

17,810

17,810

Depreciation

At 1 June 2022

11,543

11,543

Charge for the year

2,311

2,311

At 31 May 2023

13,854

13,854

Carrying amount

At 31 May 2023

3,956

3,956

At 31 May 2022

4,008

4,008

5

Debtors

Current

2023
£

2022
£

Other debtors

22

-

6

Creditors

Creditors: amounts falling due within one year

Note

2023
£

2022
£

Due within one year

 

Directors loan

11,597

9,625

Taxation and social security

 

-

722

Other creditors

 

31,149

9,268

 

42,746

19,615